Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant

• DOI: 10.1001/jamacardio.2023.4105
• Publication Date: 2023-11-08T16:02:57Z
• Authors: June-Wha Rhee; Raju Pillai; Tianhui He; Alysia Bosworth; Sitong Chen; Liezl Atencio; Artem Oganesyan; Kelly Peng; Tati Guzman; Kara Lukas; Brianna Sigala; Aleksi Iukuridze; Lanie Lindenfeld; Faizi Jamal; Pradeep Natarajan; Scott Goldsmith; Amrita Krishnan; Michael Rosenzweig; F. Lennie Wong; Stephen J. Forman; Saro Armenian
• Keywords: Cumulative incidence

There is a paucity of information on the association between clonal hematopoiesis indeterminate potential (CHIP) and cardiovascular disease (CVD) in patients with cancer, including those multiple myeloma (MM) undergoing hematopoietic cell transplant (HCT), population at high risk developing CVD after HCT.